Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.
Li X, Ominsky MS, Warmington KS, Morony S, Gong J, Cao J, Gao Y, Shalhoub V, Tipton B, Haldankar R, Chen Q, Winters A, Boone T, Geng Z, Niu QT, Ke HZ, Kostenuik PJ, Simonet WS, Lacey DL, Paszty C.
Li X, et al. Among authors: ke hz.
J Bone Miner Res. 2009 Apr;24(4):578-88. doi: 10.1359/jbmr.081206.
J Bone Miner Res. 2009.
PMID: 19049336
Free article.